Three-Dimensional Quantitative Structure−Activity Relationship of Nucleosides Acting at the A3Adenosine Receptor: Analysis of Binding and Relative Efficacy
- 6 March 2007
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 47 (3) , 1225-1233
- https://doi.org/10.1021/ci600501z
Abstract
The binding affinity and relative maximal efficacy of human A3 adenosine receptor (AR) agonists were each subjected to ligand-based three-dimensional quantitative structure−activity relationship analysis. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) used as training sets a series of 91 structurally diverse adenosine analogues with modifications at the N6 and C2 positions of the adenine ring and at the 3‘, 4‘, and 5‘ positions of the ribose moiety. The CoMFA and CoMSIA models yielded significant cross-validated q2 values of 0.53 (r2 = 0.92) and 0.59 (r2 = 0.92), respectively, and were further validated by an external test set (25 adenosine derivatives), resulting in the best predictive r2 values of 0.84 and 0.70 in each model. Both the CoMFA and the CoMSIA maps for steric or hydrophobic, electrostatic, and hydrogen-bonding interactions well reflected the nature of the putative binding site previously obtained by molecular docking. A conformationally restricted bulky group at the N6 or C2 position of the adenine ring and a hydrophilic and/or H-bonding group at the 5‘ position were predicted to increase A3AR binding affinity. A small hydrophobic group at N6 promotes receptor activation. A hydrophilic and hydrogen-bonding moiety at the 5‘ position appears to contribute to the receptor activation process, associated with the conformational change of transmembrane domains 5, 6, and 7. The 3D-CoMFA/CoMSIA model correlates well with previous receptor-docking results, current data of A3AR agonists, and the successful conversion of the A3AR agonist into antagonists by substitution (at N6) or conformational constraint (at 5‘-N-methyluronamide).Keywords
This publication has 37 references indexed in Scilit:
- 2-Triazole-Substituted Adenosines: A New Class of Selective A3Adenosine Receptor Agonists, Partial Agonists, and AntagonistsJournal of Medicinal Chemistry, 2006
- Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5′-ribofuran-uronamide moietyBioorganic & Medicinal Chemistry Letters, 2006
- Structure−Activity Relationships of 2-Chloro-N6-substituted-4‘-thioadenosine-5‘-uronamides as Highly Potent and Selective Agonists at the Human A3 Adenosine ReceptorJournal of Medicinal Chemistry, 2005
- Exploring distal regions of the A3 adenosine receptor binding site: sterically constrained N6-(2-phenylethyl)adenosine derivatives as potent ligandsBioorganic & Medicinal Chemistry, 2004
- Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-positionBioorganic & Medicinal Chemistry, 2004
- A3 Adenosine Receptor Activation in Melanoma CellsJournal of Biological Chemistry, 2003
- Usefulness of adenosine in diagnosis of tachyarrhythmiasThe American Journal of Cardiology, 1995
- Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological ActivityJournal of Medicinal Chemistry, 1994
- Definition and display of steric, hydrophobic, and hydrogen bonding properties of ligand binding sites in proteins using Lee and Richards accessible surface: validation of a high-resolution graphical tool for drug designJournal of Medicinal Chemistry, 1992
- Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibioticsJournal of Chemical Information and Computer Sciences, 1989